TransMedics Group Inc.

NASDAQ: TMDX · Real-Time Price · USD
125.64
-1.91 (-1.50%)
At close: Aug 18, 2025, 3:59 PM
126.30
0.53%
After-hours: Aug 18, 2025, 07:56 PM EDT

TransMedics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
35.46M -25.03M -36.23M -44.22M
Depreciation & Amortization
19.76M 8.18M 3.48M 1.82M
Stock-Based Compensation
33.22M 19.79M 10.32M 6.88M
Other Working Capital
-941K 10.6M 6.21M 1.97M
Other Non-Cash Items
5.36M 30.04M 3.37M 1.37M
Deferred Income Tax
n/a -1.66M n/a 2.28M
Change in Working Capital
-45M -44.35M -26.76M 3M
Operating Cash Flow
48.8M -13.03M -45.82M -28.86M
Capital Expenditures
-129.74M -179.06M -11.91M -3.52M
Cash Acquisitions
441K -14.89M 107K -32.79M
Purchase of Investments
n/a n/a -10.5M -72.02M
Sales Maturities Of Investments
n/a n/a 76.92M 104.81M
Other Investing Acitivies
-129.74M -27.21M -107K 32.79M
Investing Cash Flow
-129.3M -193.95M 54.51M 29.27M
Debt Repayment
n/a 445.38M 22.46M n/a
Common Stock Repurchased
n/a 955K n/a 419K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
22.87M -52.07M 5.61M 1.39M
Financial Cash Flow
22.87M 400.42M 167.93M 1.39M
Net Cash Flow
-58.16M 193.63M 175.6M 999K
Free Cash Flow
-80.94M -192.09M -57.72M -32.38M